144 related articles for article (PubMed ID: 12857746)
1. Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling.
Ueki N; Hayman MJ
J Biol Chem; 2003 Aug; 278(35):32489-92. PubMed ID: 12857746
[TBL] [Abstract][Full Text] [Related]
2. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation.
Prunier C; Pessah M; Ferrand N; Seo SR; Howe P; Atfi A
J Biol Chem; 2003 Jul; 278(28):26249-57. PubMed ID: 12732634
[TBL] [Abstract][Full Text] [Related]
3. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
[TBL] [Abstract][Full Text] [Related]
4. Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski.
Takeda M; Mizuide M; Oka M; Watabe T; Inoue H; Suzuki H; Fujita T; Imamura T; Miyazono K; Miyazawa K
Mol Biol Cell; 2004 Mar; 15(3):963-72. PubMed ID: 14699069
[TBL] [Abstract][Full Text] [Related]
5. Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription.
Shi X; Bai S; Li L; Cao X
J Biol Chem; 2001 Jan; 276(1):850-5. PubMed ID: 11042172
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling.
Sun Y; Liu X; Eaton EN; Lane WS; Lodish HF; Weinberg RA
Mol Cell; 1999 Oct; 4(4):499-509. PubMed ID: 10549282
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3.
Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I
J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function.
Choy L; Derynck R
J Biol Chem; 2003 Mar; 278(11):9609-19. PubMed ID: 12524424
[TBL] [Abstract][Full Text] [Related]
9. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4.
Chang CC; Lin DY; Fang HI; Chen RH; Shih HM
J Biol Chem; 2005 Mar; 280(11):10164-73. PubMed ID: 15637079
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
11. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
12. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
Poncelet AC; Schnaper HW
J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
14. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.
Liu D; Black BL; Derynck R
Genes Dev; 2001 Nov; 15(22):2950-66. PubMed ID: 11711431
[TBL] [Abstract][Full Text] [Related]
16. c-Jun associates with the oncoprotein Ski and suppresses Smad2 transcriptional activity.
Pessah M; Marais J; Prunier C; Ferrand N; Lallemand F; Mauviel A; Atfi A
J Biol Chem; 2002 Aug; 277(32):29094-100. PubMed ID: 12034730
[TBL] [Abstract][Full Text] [Related]
17. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
Harada J; Kokura K; Kanei-Ishii C; Nomura T; Khan MM; Kim Y; Ishii S
J Biol Chem; 2003 Oct; 278(40):38998-9005. PubMed ID: 12874272
[TBL] [Abstract][Full Text] [Related]
18. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
[TBL] [Abstract][Full Text] [Related]
19. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling.
Wu JW; Krawitz AR; Chai J; Li W; Zhang F; Luo K; Shi Y
Cell; 2002 Nov; 111(3):357-67. PubMed ID: 12419246
[TBL] [Abstract][Full Text] [Related]
20. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.
Furuhashi M; Yagi K; Yamamoto H; Furukawa Y; Shimada S; Nakamura Y; Kikuchi A; Miyazono K; Kato M
Mol Cell Biol; 2001 Aug; 21(15):5132-41. PubMed ID: 11438668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
